Effects and risks of endocrine disrupting chemicals
2 works
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
226
Citations
7
h-index
4
i10-index
D.B. Stedman is an academic researcher from Pfizer (United States). The author has contributed to research in topics: Effects and risks of endocrine disrupting chemicals & Monoclonal and Polyclonal Antibodies Research & Zebrafish Biomedical Research Applications. The author has an h-index of 7, co-authored 9 publications.
Click to start Chat